Market Cap
GlaxoSmithKline plc Market Capitalization:
£61.60 Billion
GBP as of July 1, 2024
US$77.93 Billion
GlaxoSmithKline plc Main Stock Listing
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$808.65 B |
|
Johnson & Johnson
|
$350.63 B |
|
Merck
|
$318.75 B |
|
AbbVie
|
$295.34 B |
AstraZeneca
|
$236.45 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
Lilly
|
$808.65 B |
Novo Nordisk
|
$622.07 B |
|
UnitedHealth Group
|
$450.89 B |
|
Johnson & Johnson
|
$350.63 B |
|
Merck
|
$318.75 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Company Description
GlaxoSmithKline PLC, better known as GSK, is a pharmaceutical company. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes, and mental health, and it also has a portfolio of vaccines. Operating in more than 115 countries, GSK is also engaged in the consumer healthcare business in oral health, pain relief, respiratory, nutrition/gastro-intestinal, and skin health categories.
GlaxoSmithKline plc Categories
United Kingdom
languages
Healthcare
languages
Drug Manufacturers—General
United Kingdom Healthcare
United Kingdom Drug Manufacturers—General
What is a company's market capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.